-
Je něco špatně v tomto záznamu ?
Metformin suppresses pregnane X receptor (PXR)-regulated transactivation of CYP3A4 gene
L. Krausova, L. Stejskalova, H. Wang, R. Vrzal, Z. Dvorak, S. Mani, P. Pavek
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem
- MeSH
- aktivace transkripce MeSH
- cytochrom P-450 CYP3A genetika metabolismus MeSH
- hepatocyty účinky léků metabolismus MeSH
- hypoglykemika farmakologie MeSH
- koaktivátory jaderných receptorů metabolismus MeSH
- kultivované buňky MeSH
- lidé MeSH
- membránové proteiny genetika metabolismus MeSH
- messenger RNA metabolismus MeSH
- metformin farmakologie MeSH
- myši inbrední C57BL MeSH
- myši knockoutované MeSH
- myši MeSH
- polohový reflex účinky léků MeSH
- proteinkinasy aktivované AMP fyziologie MeSH
- receptory cytoplazmatické a nukleární metabolismus fyziologie MeSH
- receptory glukokortikoidů fyziologie MeSH
- receptory kalcitriolu fyziologie MeSH
- reportérové geny MeSH
- signální transdukce MeSH
- steroidní receptory genetika fyziologie MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Research Support, N.I.H., Extramural MeSH
Metformin is widely used in the treatment of type-2 diabetes. The pleotropic effects of metformin on glucose and lipid metabolism have been proposed to be mediated by the activation of AMP-activated protein kinase (AMPK) and the subsequent up-regulation of small heterodimer partner (SHP). SHP suppresses the functions of several nuclear receptors involved in the regulation of hepatic metabolism, including pregnane X receptor (PXR), which is referred to as a "master regulator" of drug/xenobiotic metabolism. In this study, we hypothesize that metformin suppresses the expression of CYP3A4, a main detoxification enzyme and a target gene of PXR, due to SHP up-regulation. We employed various gene reporter assays in cell lines and qRT-PCR in human hepatocytes and in Pxr(-/-) mice. We show that metformin dramatically suppresses PXR-mediated expression of CYP3A4 in hepatocytes. Consistently, metformin significantly suppressed the up-regulation of Cyp3a11 mRNA in the liver and intestine of wild-type mice, but not in Pxr(-/-) mice. A mechanistic investigation of the phenomenon showed that metformin does not significantly up-regulate SHP in human hepatocytes. We further demonstrate that AMPK activation is not involved in this process. We show that metformin disrupts PXR's interaction with steroid receptor coactivator-1 (SRC1) in a two-hybrid assay independently of the PXR ligand binding pocket. Metformin also inhibited vitamin D receptor-, glucocorticoid receptor- and constitutive androstane receptor (CAR)-mediated induction of CYP3A4 mRNA in human hepatocytes. We show, therefore, a suppressive effect of metformin on PXR and other ligand-activated nuclear receptors in transactivation of the main detoxification enzyme CYP3A4 in human hepatocytes.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12022121
- 003
- CZ-PrNML
- 005
- 20151013150322.0
- 007
- ta
- 008
- 120806s2011 xxk f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.bcp.2011.08.023 $2 doi
- 035 __
- $a (PubMed)21920351
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Krausová, Lucie $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University in Prague, Heyrovskeho 1203, Hradec Kralove, Czech Republic $7 xx0122166
- 245 10
- $a Metformin suppresses pregnane X receptor (PXR)-regulated transactivation of CYP3A4 gene / $c L. Krausova, L. Stejskalova, H. Wang, R. Vrzal, Z. Dvorak, S. Mani, P. Pavek
- 520 9_
- $a Metformin is widely used in the treatment of type-2 diabetes. The pleotropic effects of metformin on glucose and lipid metabolism have been proposed to be mediated by the activation of AMP-activated protein kinase (AMPK) and the subsequent up-regulation of small heterodimer partner (SHP). SHP suppresses the functions of several nuclear receptors involved in the regulation of hepatic metabolism, including pregnane X receptor (PXR), which is referred to as a "master regulator" of drug/xenobiotic metabolism. In this study, we hypothesize that metformin suppresses the expression of CYP3A4, a main detoxification enzyme and a target gene of PXR, due to SHP up-regulation. We employed various gene reporter assays in cell lines and qRT-PCR in human hepatocytes and in Pxr(-/-) mice. We show that metformin dramatically suppresses PXR-mediated expression of CYP3A4 in hepatocytes. Consistently, metformin significantly suppressed the up-regulation of Cyp3a11 mRNA in the liver and intestine of wild-type mice, but not in Pxr(-/-) mice. A mechanistic investigation of the phenomenon showed that metformin does not significantly up-regulate SHP in human hepatocytes. We further demonstrate that AMPK activation is not involved in this process. We show that metformin disrupts PXR's interaction with steroid receptor coactivator-1 (SRC1) in a two-hybrid assay independently of the PXR ligand binding pocket. Metformin also inhibited vitamin D receptor-, glucocorticoid receptor- and constitutive androstane receptor (CAR)-mediated induction of CYP3A4 mRNA in human hepatocytes. We show, therefore, a suppressive effect of metformin on PXR and other ligand-activated nuclear receptors in transactivation of the main detoxification enzyme CYP3A4 in human hepatocytes.
- 650 _2
- $a proteinkinasy aktivované AMP $x fyziologie $7 D055372
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a kultivované buňky $7 D002478
- 650 _2
- $a cytochrom P-450 CYP3A $x genetika $x metabolismus $7 D051544
- 650 _2
- $a reportérové geny $7 D017930
- 650 _2
- $a hepatocyty $x účinky léků $x metabolismus $7 D022781
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hypoglykemika $x farmakologie $7 D007004
- 650 _2
- $a membránové proteiny $x genetika $x metabolismus $7 D008565
- 650 _2
- $a metformin $x farmakologie $7 D008687
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a myši inbrední C57BL $7 D008810
- 650 _2
- $a myši knockoutované $7 D018345
- 650 _2
- $a koaktivátory jaderných receptorů $x metabolismus $7 D056918
- 650 _2
- $a messenger RNA $x metabolismus $7 D012333
- 650 _2
- $a receptory kalcitriolu $x fyziologie $7 D018167
- 650 _2
- $a receptory cytoplazmatické a nukleární $x metabolismus $x fyziologie $7 D018160
- 650 _2
- $a receptory glukokortikoidů $x fyziologie $7 D011965
- 650 _2
- $a steroidní receptory $x genetika $x fyziologie $7 D011987
- 650 _2
- $a polohový reflex $x účinky léků $7 D057897
- 650 _2
- $a signální transdukce $7 D015398
- 650 _2
- $a aktivace transkripce $7 D015533
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a Research Support, N.I.H., Extramural $7 D052061
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Stejskalová, Lucie $7 xx0142114 $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University in Prague, Heyrovskeho 1203, Hradec Kralove, Czech Republic
- 700 1_
- $a Wang, Hongwei $u Albert Einstein Cancer Center, Albert Einstein College of Medicine, 1300 Morris Park Ave, Chanin 302D-1 Bronx, NY 1046, United States
- 700 1_
- $a Vrzal, Radim $7 xx0118949 $u Department of Cell Biology and Genetics, Faculty of Science, Palacky University in Olomouc, Slechtitelu 11, Olomouc, Czech Republic
- 700 1_
- $a Dvořák, Zdeněk, $d 1974- $7 xx0118950 $u Department of Cell Biology and Genetics, Faculty of Science, Palacky University in Olomouc, Slechtitelu 11, Olomouc, Czech Republic
- 700 1_
- $a Mani, Sridhar $u Albert Einstein Cancer Center, Albert Einstein College of Medicine, 1300 Morris Park Ave, Chanin 302D-1 Bronx, NY 1046, United States
- 700 1_
- $a Pávek, Petr $7 xx0093070 $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University in Prague, Heyrovskeho 1203, Hradec Kralove, Czech Republic
- 773 0_
- $w MED00000704 $t Biochemical pharmacology $x 1873-2968 $g Roč. 82, č. 11 (2011), s. 1771-1780
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/21920351 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m $z 0
- 990 __
- $a 20120806 $b ABA008
- 991 __
- $a 20151013150511 $b ABA008
- 999 __
- $a ok $b bmc $g 944034 $s 779418
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2011 $b 82 $c 11 $d 1771-1780 $e 20110906 $i 1873-2968 $m Biochemical pharmacology $n Biochem Pharmacol $x MED00000704
- LZP __
- $b NLK111 $a Pubmed-20120806/12/01